Publications 2023

Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, Yang W, Nissen-Meyer LSH, Douvlataniotis K, Laos M, Nielsen MM, Thiede B, Søraas A, Lund-Johansen F, Rustad EH, Olweus J (2023)
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
Cell Rep, 42 (1), 111995
DOI 10.1016/j.celrep.2023.111995, PubMed 36656713

Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K et al. (2023)
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Blood Adv, 7 (23), 7216-7230
DOI 10.1182/bloodadvances.2023010158, PubMed 37695745

Publications 2022

Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
Br J Haematol, 197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660

Publications 2021

Buspavanich P, Adli M, Himmerich H, Berger M, Busche M, Schlattmann P, Bopp S, Bschor T, Richter C, Steinacher B, Stoppel C, Hindinger C, Meyer S, Hoffmann K, Stamm T, Gabriel A, Merkl A, Goerke-Arndt F, Köhler S, Sterzer P, Heinz A, Behr J, Fakhri H, Lang F, Lang UE et al. (2021)
Faster speed of onset of the depressive episode is associated with lower cytokine serum levels (IL-2, -4, -6, -10, TNF-α and IFN-γ) in patients with major depression
J Psychiatr Res, 141, 287-292
DOI 10.1016/j.jpsychires.2021.06.033, PubMed 34271459

Mester S, Evers M, Meyer S, Nilsen J, Greiff V, Sandlie I, Leusen J, Andersen JT (2021)
Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo
MAbs, 13 (1), 1893888
DOI 10.1080/19420862.2021.1893888, PubMed 33691596

Publications 2020

Evers M, Ten Broeke T, Jansen JHM, Nederend M, Hamdan F, Reiding KR, Meyer S, Moerer P, Brinkman I, Rösner T, Lebbink RJ, Valerius T, Leusen JHW (2020)
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
MAbs, 12 (1), 1795505
DOI 10.1080/19420862.2020.1795505, PubMed 32744145

Publications 2018

Meyer S, Evers M, Jansen JHM, Buijs J, Broek B, Reitsma SE, Moerer P, Amini M, Kretschmer A, Ten Broeke T, den Hartog MT, Rijke M, Klein C, Valerius T, Boross P, Leusen JHW (2018)
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
Br J Haematol, 180 (6), 808-820
DOI 10.1111/bjh.15132, PubMed 29468712

Publications 2017

Lohse S, Loew S, Kretschmer A, Jansen JHM, Meyer S, Ten Broeke T, Rösner T, Dechant M, Derer S, Klausz K, Kellner C, Schwanbeck R, French RR, Tipton TRW, Cragg MS, Schewe DM, Peipp M, Leusen JHW, Valerius T (2017)
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity
Br J Haematol, 181 (3), 413-417
DOI 10.1111/bjh.14624, PubMed 28449349

Publications 2016

Gräske J, Meyer S, Schmidt A, Schmidt S, Laporte Uribe F, Thyrian JR, Schäfer-Walkmann S, Wolf-Ostermann K (2016)
[Regional Dementia Care Networks in Germany--results from the DemNet-D-Study regarding the quality of life of their users]
Pflege, 29 (2), 93-101
DOI 10.1024/1012-5302/a000477, PubMed 26974281

Wolf-Ostermann K, Meyer S, Schmidt A, Schritz A, Holle B, Wübbeler M, Schäfer-Walkmann S, Gräske J (2016)
[Users of regional dementia care networks in Germany : First results of the evaluation study DemNet-D]
Z Gerontol Geriatr, 50 (1), 21-27
DOI 10.1007/s00391-015-1006-9, PubMed 26779703

Publications 2015

Brandsma AM, Jacobino SR, Meyer S, ten Broeke T, Leusen JH (2015)
Fc receptor inside-out signaling and possible impact on antibody therapy
Immunol Rev, 268 (1), 74-87
DOI 10.1111/imr.12332, PubMed 26497514

Brandsma AM, Ten Broeke T, Nederend M, Meulenbroek LA, van Tetering G, Meyer S, Jansen JH, Beltrán Buitrago MA, Nagelkerke SQ, Németh I, Ubink R, Rouwendal G, Lohse S, Valerius T, Leusen JH, Boross P (2015)
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing
Cancer Immunol Res, 3 (12), 1316-24
DOI 10.1158/2326-6066.CIR-15-0099-T, PubMed 26407589

Gräske J, Meyer S, Worch A, Wolf-Ostermann K (2015)
Family visits in shared-housing arrangements for residents with dementia--a cross-sectional study on the impact on residents' quality of life
BMC Geriatr, 15, 14
DOI 10.1186/s12877-015-0012-5, PubMed 25868401

Lohse S, Meyer S, Meulenbroek LA, Jansen JH, Nederend M, Kretschmer A, Klausz K, Möginger U, Derer S, Rösner T, Kellner C, Schewe D, Sondermann P, Tiwari S, Kolarich D, Peipp M, Leusen JH, Valerius T (2015)
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Cancer Res, 76 (2), 403-17
DOI 10.1158/0008-5472.CAN-15-1232, PubMed 26634925

Meyer S, Gräske J, Worch A, Wolf-Ostermann K (2015)
Nutritional status of care-dependent people with dementia in shared-housing arrangements--a one-year follow-up
Scand J Caring Sci, 29 (4), 785-92
DOI 10.1111/scs.12210, PubMed 25756829

Meyer S, Nederend M, Jansen JH, Reiding KR, Jacobino SR, Meeldijk J, Bovenschen N, Wuhrer M, Valerius T, Ubink R, Boross P, Rouwendal G, Leusen JH (2015)
Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting
MAbs, 8 (1), 87-98
DOI 10.1080/19420862.2015.1106658, PubMed 26466856

Rouwendal GJ, van der Lee MM, Meyer S, Reiding KR, Schouten J, de Roo G, Egging DF, Leusen JH, Boross P, Wuhrer M, Verheijden GF, Dokter WH, Timmers M, Ubink R (2015)
A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA
MAbs, 8 (1), 74-86
DOI 10.1080/19420862.2015.1102812, PubMed 26440530

Wübbeler M, Wucherer D, Hertel J, Michalowsky B, Heinrich S, Meyer S, Schaefer-Walkmann S, Hoffmann W, Thyrian JR (2015)
Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use
BMC Health Serv Res, 15, 205
DOI 10.1186/s12913-015-0855-7, PubMed 25998147

Publications 2014

Boross P, Jansen JH, van Tetering G, Nederend M, Brandsma A, Meyer S, Torfs E, van den Ham HJ, Meulenbroek L, de Haij S, Leusen JH (2014)
Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice
Immunol Lett, 160 (2), 151-7
DOI 10.1016/j.imlet.2014.02.005, PubMed 24613852

Gräske J, Meyer S, Wolf-Ostermann K (2014)
Quality of life ratings in dementia care--a cross-sectional study to identify factors associated with proxy-ratings
Health Qual Life Outcomes, 12, 177
DOI 10.1186/s12955-014-0177-1, PubMed 25495548

Meyer S, Fleischer-Schlechtiger N, Gräske J, Worch A, Wolf-Ostermann K (2014)
[Comparison of the nutritional status of residents in shared-housing arrangements and nursing homes: a secondary data analysis]
Pflege Z, 67 (4), 224-9
PubMed 24826428

Meyer S, Leusen JH, Boross P (2014)
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer
MAbs, 6 (5), 1133-44
DOI 10.4161/mabs.29670, PubMed 25517299

Wolf-Ostermann K, Meyer S, Gräske J (2014)
[Nursing science and nursing research in Germany profit from international contacts. Looking at the big picture]
Pflege Z, 67 (5), 270-3
PubMed 24868701

Publications 2013

Wolf-Ostermann K, Worch A, Meyer S, Gräske J (2013)
Quality of care and its impact on quality of life for care-dependent persons with dementia in shared-housing arrangements: results of the Berlin WGQual-study
Appl Nurs Res, 27 (1), 33-40
DOI 10.1016/j.apnr.2013.11.002, PubMed 24393516